JPRN-UMIN000038760已完成未知
Study of the immunogenicity of 13-valent pneumococcal conjugate vaccine in high-risk patients who were outside recommended ages for routine vaccination - Study of the immunogenicity of PCV13 in high-risk patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who were determined as unsuitable subjects by investigators.
研究者
相似试验
招募中
2 期
Immunogenicity and Safety of a 13-valent pneumococcal conjugate vaccine in paediatric oncology patientspaediatric malignancyCancer - Children's - BrainCancer - Children's - Leukaemia & LymphomaCancer - Children's - OtherACTRN12613000264785Te-Yu Hung100
已完成
不适用
Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Korean Elderly PeopleCertain infectious and parasitic diseasesKCT0001963Ewha Womans University100
尚未招募
4 期
Immunogenicity and Safety of Pneumococcal 13-valent Conjugate Vaccine between Weuphoria and Prevnar 13 in Thai Older PeopleHealthy participants with no health conditions or stable chronic diseases.-TCTR20230923001ational Vaccine Institute (NVI)408
进行中（未招募）
不适用
Evaluation of immunogenicity of 7-valent Pneumococcal Conjugate Vaccine (Prevenar) and Hexavalent DtPa-HBV-IPV-Hib (InfaNrix Hexa), co-administered at the same time, versus Hexavalent vaccine, used in primary immunization schedule - NDHealthy childrenMedDRA version: 6.1Level: PTClassification code 10062163EUCTR2007-003692-39-ITAZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO GENOVA
已完成
4 期
Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina FasoPneumococcal InfectionsNCT01577771Agence de Médecine Préventive, France663